XOMA Royalty Quote - XOMA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

27.13

Bid

13.67

Offer

28.00

Volume

122,834

25.205 Day's Range 27.49

17.52 52 Week Range 35.00

Market Cap

319.665M

Previous Close

25.11

Open

26.33

Last Trade

Last Trade Time

Financial Volume

US$ 3,237,559

VWAP

26.3572

Average Volume (3m)

27,271

Shares Outstanding

11,782,723

Dividend Yield

PE Ratio

-7.75

Earnings Per Share (EPS)

-3.47

Revenue

4.76M

Net Profit

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xoma.com

Headquarters

Wilmington, Delaware, USA

Founded

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMA. The last closing price for XOMA Royalty was US$25.11. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 17.52 to US$ 35.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$295.86 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.75.

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.87	-3.10714285714	28	28.57	24.85	27690	26.11033933	CS
4	-3.06	-10.1358065585	30.19	35	24.85	32739	30.08901122	CS
12	1.33	5.15503875969	25.8	35	24.85	27271	29.7140854	CS
26	4.74	21.1701652523	22.39	35	21.27	26605	28.11062844	CS
52	9.01	49.7240618102	18.12	35	17.52	22772	25.9742853	CS
156	5.55	25.718257646	21.58	35	13.48	29928	21.24689904	CS
260	2.63	10.7346938776	24.5	46.32	13.48	34887	24.5240451	CS

XOMA - Frequently Asked Questions (FAQ)

What is the current XOMA Royalty share price?

The current share price of XOMA Royalty is US$ 27.13

How many XOMA Royalty shares are in issue?

XOMA Royalty has 11,782,723 shares in issue

What is the market cap of XOMA Royalty?

The market capitalisation of XOMA Royalty is USD 295.86M

What is the 1 year trading range for XOMA Royalty share price?

XOMA Royalty has traded in the range of US$ 17.52 to US$ 35.00 during the past year

What is the PE ratio of XOMA Royalty?

The price to earnings ratio of XOMA Royalty is -7.75

What is the cash to sales ratio of XOMA Royalty?

The cash to sales ratio of XOMA Royalty is 66.49

What is the reporting currency for XOMA Royalty?

XOMA Royalty reports financial results in USD

What is the latest annual turnover for XOMA Royalty?

The latest annual turnover of XOMA Royalty is USD 4.76M

What is the latest annual profit for XOMA Royalty?

The latest annual profit of XOMA Royalty is USD -40.83M

What is the registered address of XOMA Royalty?

The registered address for XOMA Royalty is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the XOMA Royalty website address?

The website address for XOMA Royalty is www.xoma.com

Which industry sector does XOMA Royalty operate in?

XOMA Royalty operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M